Gainers
- Cyclerion Therapeutics CYCN inventory rose 47.4% to $4.45 throughout Tuesday’s after-market session. The market worth of their excellent shares is at $9.7 million.
- Utilized Therapeutics APLT shares rose 11.21% to $0.5. The market worth of their excellent shares is at $68.5 million.
- Rallybio RLYB shares rose 6.29% to $0.62. The market worth of their excellent shares is at $25.4 million.
- SAB Biotherapeutics SABS inventory elevated by 6.19% to $2.4. The corporate’s market cap stands at $23.0 million.
- AN2 Therapeutics ANTX shares moved upwards by 5.79% to $1.35. The market worth of their excellent shares is at $36.6 million.
- Adaptimmune Therapeutics ADAP inventory moved upwards by 5.26% to $0.16. The market worth of their excellent shares is at $44.3 million.
Losers
- Aytu BioPharma AYTU inventory decreased by 13.3% to $2.22 throughout Tuesday’s after-market session. The corporate’s market cap stands at $22.3 million. As per the information, the This autumn earnings report got here out at this time.
- Incannex Healthcare IXHL inventory declined by 10.66% to $0.6. The corporate’s market cap stands at $38.5 million.
- Soligenix SNGX inventory fell 5.65% to $1.84. The market worth of their excellent shares is at $7.6 million.
- Apimeds Prescription drugs APUS inventory fell 4.69% to $1.83. The corporate’s market cap stands at $24.6 million.
- Basel Medical Group BMGL shares declined by 4.22% to $1.82. The corporate’s market cap stands at $33.4 million.
- Test-Cap CHEK shares declined by 3.75% to $2.16. The corporate’s market cap stands at $14.3 million.
See Additionally: www.benzinga.com/cash/best-healthcare-stocks/
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.